Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma

Acta Cytologica

Volumn 57, Issue 3, 2013, Pages 252-258

  Chung, Soo Young ^a   Lee, Jae Seok ^b   Lee, Hyebin ^c   Park, Sung Hee ^d   Kim, Soo Jin ^d   Ryu, Han Suk ^d  

^a Dongnam Institute of Radiological and Medical Science   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Fine needle aspiration biopsy; Hobnail features; Liquid based cytology; Lymph node metastasis; Papillary thyroid carcinoma

Indexed keywords

B RAF KINASE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CELL STRUCTURE; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LIQUID BASED FINE NEEDLE ASPIRATION; LYMPH NODE METASTASIS; MACROPHAGE; MALE; MUTATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR CELL; AGED; CLINICAL EVALUATION; GENE MUTATION; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PREOPERATIVE EVALUATION; RISK FACTOR; TUMOR VOLUME;

EID: 84876814390     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000343617     Document Type: Article

References (26)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, Mc-Iver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM: Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19: 1167-1214.
2. Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV: Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 2010; 34: 44-52.
3. Liu Z, Kakudo K, Bai Y, Li Y, Ozaki T, Miyauchi A, Taniguchi E, Mori I: Loss of cellular polarity/cohesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis; possible morphological indicator of epithelial mesenchymal transition. J Clin Pathol 2011; 64: 325-329.
4. Renshaw AA: 'Histiocytoid' cells in fineneedle aspirations of papillary carcinoma of the thyroid: frequency and significance of an under-recognized cytologic pattern. Cancer 2002; 96: 240-243.
5. Geers C, Bourgain C: Liquid-based FNAC of the thyroid: a 4-year survey with SurePath. Cancer Cytopathol 2011; 119: 58-67.
6. Jung CK, Lee A, Jung ES, Choi YJ, Jung SL, Lee KY: Split sample comparison of a liquidbased method and conventional smears in thyroid fine needle aspiration. Acta Cytol 2008; 52: 313-319.
7. Stamataki M, Anninos D, Brountzos E, Georgoulakis J, Panayiotides J, Christoni Z, Peros G, Karakitsos P: The role of liquidbased cytology in the investigation of thyroid lesions. Cytopathology 2008; 19: 11-18.
8. Fadda G, Rossi ED: Liquid-based cytology in fine-needle aspiration biopsies of the thyroid gland. Acta Cytol 2011; 55: 389-400.
9. Rossi ED, Fadda G: Thin-layer liquid-based preparation of non-gynaecological exfoliative and fine-needle aspiration biopsy cytology. Diagn Histopathol 2008; 14: 563-570.
10. Michael CW, Pang Y, Pu RT, Hasteh F, Griffith KA: Cellular adequacy for thyroid aspirates prepared by ThinPrep: how many cells are needed? Diagn Cytopathol 2007; 35: 792-797.
11. Boerner SL, Asa SL: Biopsy Interpretation of the Thyroid. Philadelphia, Lippincott Williams & Wilkins, 2010, pp 103-125.
12. Yang GC, Stern CM, Messina AV: Cystic papillary thyroid carcinoma in fine needle aspiration may represent a subset of the encapsulated variant in WHO classification. Diagn Cytopathol 2010; 38: 721-726.
13. Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH: BRAF V600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAF V600E-prevalent population. J Clin Endocrinol Metab 2010; 95: 3693-3700.
14. Grebe SK, Hay ID: Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996; 5: 43-63.
15. Nam-Goong IS, Kim HY, Gong G, Lee HK, Hong SJ, Kim WB, Shong YK: Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004; 60: 21-28.
16. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A: An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 2003; 13: 381-387.
17. Solorzano CC, Carneiro DM, Ramirez M, Lee TM, Irvin GL 3rd: Surgeon-performed ultrasound in the management of thyroid malignancy. Am Surg 2004; 70: 576-580, discussion 580-582.
18. Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, Hartl DM, Lassau N, Baudin E, Schlumberger M: Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer. J Clin Endocrinol Metab 2007; 92: 3590-3594.
19. Tang W, Nakamura Y, Zuo H, Yasuoka H, Yang Q, Wang X, Nakamura M, Mori I, Miyauchi A, Kakudo K: Differentiation, proliferation and retinoid receptor status of papillary carcinoma of the thyroid. Pathol Int 2003; 53: 204-213.
20. Michael CW, McConnel J, Pecott J, Afify AM, Al-Khafaji B: Comparison of ThinPrep and TriPath PREP liquid-based preparations in nongynecologic specimens: a pilot study. Diagn Cytopathol 2001; 25: 177-184.
21. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R: BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol 2009; 27: 2977-2982.
22. Xing M: BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 2007; 28: 742-762.
23. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV: BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 2006; 15: 136-143.
24. Kim TY, Kim WB, Song JY, Rhee YS, Gong G, Cho YM, Kim SY, Kim SC, Hong SJ, Shong YK: The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin Endocrinol (Oxf) 2005; 63: 588-593.
25. Nam JK, Jung CK, Song BJ, Lim DJ, Chae BJ, Lee NS, Park WC, Kim JS, Jung SS, Bae JS: Is the BRAF(V600E) mutation useful as a predictor of preoperative risk in papillary thyroid cancer? Am J Surg 2012; 203: 436-441.
26. Ito Y, Yoshida H, Maruo R, Morita S, Takano T, Hirokawa M, Yabuta T, Fukushima M, Inoue H, Tomoda C, Kihara M, Uruno T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A: BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr J 2009; 56: 89-97.